Revolution Medicines (RVMD) Amortizatization of Intangibles (2019 - 2025)
Revolution Medicines has reported Amortizatization of Intangibles over the past 7 years, most recently at $99000.0 for Q4 2025.
- Quarterly results put Amortizatization of Intangibles at $99000.0 for Q4 2025, down 99.77% from a year ago — trailing twelve months through Dec 2025 was $966000.0 (down 97.87% YoY), and the annual figure for FY2025 was $900000.0, down 97.98%.
- Amortizatization of Intangibles for Q4 2025 was $99000.0 at Revolution Medicines, down from $300000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for RVMD hit a ceiling of $43.8 million in Q4 2024 and a floor of -$10.4 million in Q4 2023.
- Median Amortizatization of Intangibles over the past 5 years was $300000.0 (2021), compared with a mean of $2.2 million.
- Biggest five-year swings in Amortizatization of Intangibles: tumbled 1789.41% in 2023 and later surged 521.89% in 2024.
- Revolution Medicines' Amortizatization of Intangibles stood at $3.2 million in 2021, then plummeted by 80.93% to $614000.0 in 2022, then tumbled by 1789.41% to -$10.4 million in 2023, then surged by 521.89% to $43.8 million in 2024, then crashed by 99.77% to $99000.0 in 2025.
- The last three reported values for Amortizatization of Intangibles were $99000.0 (Q4 2025), $300000.0 (Q3 2025), and $300000.0 (Q2 2025) per Business Quant data.